298000 — Hyosung Chemical Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩161bn
- KR₩3tn
- KR₩3tn
- 17
- 35
- 21
- 10
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 46,059 | 64,177 | 35,509 | 107,080 | 54,102 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 150,381 | 220,229 | 327,974 | 333,630 | 244,409 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 446,058 | 435,749 | 797,622 | 819,924 | 699,214 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,448,333 | 1,923,348 | 2,175,968 | 2,187,083 | 2,325,526 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,063,516 | 2,417,365 | 3,044,049 | 3,131,119 | 3,115,611 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 431,320 | 627,538 | 1,083,164 | 1,715,749 | 2,147,489 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,608,808 | 2,015,012 | 2,554,749 | 3,016,502 | 3,053,727 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 454,708 | 402,353 | 489,301 | 114,617 | 61,884 |
Total Liabilities & Shareholders' Equity | 2,063,516 | 2,417,365 | 3,044,049 | 3,131,119 | 3,115,611 |
Total Common Shares Outstanding |